Meeting
2021 ASCO Annual Meeting
Assessing the risk of severe post-treatment (tx) cancer-related fatigue (CRF) among breast cancer survivors (BCS) in the CANcer TOxicity (CANTO) cohort.
Authors
Antonio Di Meglio
Gustave Roussy, Villejuif, France
Antonio Di Meglio , Julie Havas , Elise Martin , Barbara Pistilli , Gwenn Menvielle , Agnes Dumas , Cecile Charles , Sibille Everhard , Anne-Laure Martin , Charles Coutant , Carole Tarpin , Laurence Vanlemmens , Christelle Levy , Olivier Rigal , Suzette Delaloge , Patricia A. Ganz , Ann H. Partridge , Fabrice Andre , Stefan Michiels , Ines Maria Vaz Duarte Luis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Symptoms and Survivorship
Track
Symptom Science and Palliative Care
Sub Track
Late and Long-Term Adverse Effects
Clinical Trial Registration Number
NCT01993498
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 12022)
DOI
10.1200/JCO.2021.39.15_suppl.12022
Abstract #
12022
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.
First Author: Arlindo R. Ferreira
Poster
2019 ASCO Annual Meeting
Impact of overweight, obesity, and post-treatment weight changes on occupational reintegration of breast cancer (BC) survivors.
First Author: Antonio Di Meglio
Poster
2019 ASCO Annual Meeting
High temporal variability of clinical side effects with and without adjuvant chemotherapy in 4,684 early breast cancer patients in the CANTO trial.
First Author: Paul H. Cottu
Poster
2019 ASCO Annual Meeting
Return to work after breast cancer: Comprehensive longitudinal analyses of its determinants.
First Author: Agnes Dumas